| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/30/2011 | US20110160195 Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation |
| 06/30/2011 | US20110160194 Anti-Inflammatory Analgesic External Preparation |
| 06/30/2011 | US20110160193 New Benzothiazinone Derivatives and Their Use as Antibacterial Agents |
| 06/30/2011 | US20110160192 Biaryl amino acids and their use in dna binding oligomers |
| 06/30/2011 | US20110160191 New fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof |
| 06/30/2011 | US20110160190 Carboline derivatives useful in the inhibition of angiogenesis |
| 06/30/2011 | US20110160189 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
| 06/30/2011 | US20110160188 Paramyxovirus family inhibitors and methods of use thereof |
| 06/30/2011 | US20110160187 3-aryl-5,6-disubstituted pyridazines |
| 06/30/2011 | US20110160186 Methods of Treating CYP2D6 Alternative Metabolizers |
| 06/30/2011 | US20110160185 Pyrrolopyrimidine derivatives as jak3 inhibitors |
| 06/30/2011 | US20110160184 Dibenzothiazepine Derivatives and Use Thereof |
| 06/30/2011 | US20110160183 Inhibitors of akt activity |
| 06/30/2011 | US20110160182 Pyrazine compounds as phosphodiesterase 10 inhibitors |
| 06/30/2011 | US20110160181 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 06/30/2011 | US20110160180 Cannabinoid Receptor Ligands |
| 06/30/2011 | US20110160179 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 06/30/2011 | US20110160178 Heterosubstituted n-thiolated beta-lactam compounds and methods of use |
| 06/30/2011 | US20110160177 Novel carbapenem derivatives |
| 06/30/2011 | US20110160176 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 06/30/2011 | US20110160175 18,21-Didesoxymacbecin Derivatives for the Treatment of Cancer |
| 06/30/2011 | US20110160174 Method Of Treating Disorder Related To High Cholesterol Concentration |
| 06/30/2011 | US20110160173 Method Of Treating Human Skin And A Skin Care Composition For Use In Such A Method |
| 06/30/2011 | US20110160172 Fluoroquinolone derivatives for ophthalmic applications |
| 06/30/2011 | US20110160171 Treatment of congestion using steroids and adrenergics |
| 06/30/2011 | US20110160170 Compositions and methods of inducing endoplasmic reticulum stress response |
| 06/30/2011 | US20110160169 Method for producing high sapogenin content composition |
| 06/30/2011 | US20110160168 Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
| 06/30/2011 | US20110160167 Steroid Derivatives Acting As Glucocorticosteroid Receptor Agonists |
| 06/30/2011 | US20110160166 Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues |
| 06/30/2011 | US20110160165 7-Pyrazolyl Tetracycline Compounds and Methods of Use Thereof |
| 06/30/2011 | US20110160164 Compounds for nonsense suppression and methods for their use |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160162 Prodrugs of a2b adenosine receptor antagonists |
| 06/30/2011 | US20110160161 Concentrated therapeutic phospholipid compositions |
| 06/30/2011 | US20110160160 Methods for heat shock protein dependent cancer treatment |
| 06/30/2011 | US20110160159 Treatment of cancer |
| 06/30/2011 | US20110160158 Methods of treatment of bipolar disorder |
| 06/30/2011 | US20110160157 Methods of treating an inflammatory-related disease |
| 06/30/2011 | US20110160156 Pharmaceutical Composition for the Eradication of Helicobacter Pylori and Preparation Method Thereof |
| 06/30/2011 | US20110160155 Composition and use of a long-acting oral bioadhesive endoparasiticide gel based on doramectin |
| 06/30/2011 | US20110160154 Substituted piperazines |
| 06/30/2011 | US20110160153 Methods and Compositions for Treating Blood Circulation Disorders |
| 06/30/2011 | US20110160152 Extracts of aquilaria hulls and use thereof in the treatment of cancer |
| 06/30/2011 | US20110160151 Novel Acetates of 2-Deoxy Monosaccharides with Anticancer Activity |
| 06/30/2011 | US20110160150 Thiol-containing compounds for the removal of elements from tissues and formulations therefor |
| 06/30/2011 | US20110160148 Novel Diverse Lead Compound Autotaxin Inhibitors |
| 06/30/2011 | US20110160136 Polyphenols for the treatment of cartilage disorders |
| 06/30/2011 | US20110160132 Lymphangiogenesis-promoting agents |
| 06/30/2011 | US20110160130 Cancer treatment method |
| 06/30/2011 | US20110160129 Therapeutic Agent Preparations for Delivery Into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device |
| 06/30/2011 | US20110160128 Corin for Treating Obesity and Diabetes |
| 06/30/2011 | US20110160127 Prodrugs of Neuraminidase Inhibitors |
| 06/30/2011 | US20110160123 Targeting the efflux systems of mycobacterium tuberculosis |
| 06/30/2011 | US20110159304 Anti-sulphate reducing bacteria composition comprising 1,2-benzisothiazol-3(2h)-one, irgasan, benzyl-2-bromoacetate, 2,2-dibromo-2-cyanoacetamide, and 2-bromo-2-nitropropan-1,3-diol |
| 06/30/2011 | US20110159169 Drug releasing coatings for medical devices |
| 06/30/2011 | US20110159114 Combination comprising an iron chelator and an anti-neoplastic agent and use thereof |
| 06/30/2011 | US20110159111 Pharmaceutical combinations |
| 06/30/2011 | US20110159106 Dermatological compositions containing an association of peroxidized lipids and zinc, and uses thereof in particular in the treatment of herpes |
| 06/30/2011 | US20110159103 Novel Preparation of an Enteric Release System |
| 06/30/2011 | US20110159100 Formulations and methods for the controlled release of active drug substances |
| 06/30/2011 | US20110159098 Stabilization and delivery of nucleic acid complexes |
| 06/30/2011 | US20110159096 1-(1H-1,2,4-Triazol-1-YL)Butan-2-OL Derivative For Pharmaceutical Use, and The Use Of a 1-(1H-1,2,4-Triazol-1-YL)Butan-2-OL Derivative With Substantially Undefined Crystal Shape For Preparing Said 1-(1H-1,2,4-Triazol-1-YL)Butan-2-OL Derivative |
| 06/30/2011 | US20110159095 Treatment of adrenal insufficiency |
| 06/30/2011 | US20110159094 Extended release compositions for high solubility, high permeability active pharmaceutical ingredients |
| 06/30/2011 | US20110159093 Modified release pharmaceutical compositions |
| 06/30/2011 | US20110159092 Extended release pharmaceutical composition comprising linezolid and process for preparing the same |
| 06/30/2011 | US20110159091 Rapidly dispersible vaginal tablet that provides a bioadhesive gel |
| 06/30/2011 | US20110159090 Abuse resistant drugs, method of use and method of making |
| 06/30/2011 | US20110159089 Abuse resistant drugs, method of use and method of making |
| 06/30/2011 | US20110159088 ORAL PHARMACEUTICAL FOR BASED ON AT LEAST ONE ACTIVE PRINCIPLE WHOSE SOLUBILITY VARIES AS A FUNCTION OF THE GASTRIC pH CONDITIONS |
| 06/30/2011 | US20110159087 Crosslinked Polymers |
| 06/30/2011 | US20110159086 Pharmaceutical formulation comprising a cb1-receptor compound in a solid solution and/or solid dispersion |
| 06/30/2011 | US20110159085 Abt-263 capsule |
| 06/30/2011 | US20110159084 Raloxifene pharmaceutical formulations |
| 06/30/2011 | US20110159082 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 06/30/2011 | US20110159080 Composition comprising liposome-entrapped doxorubicin and methods of administration |
| 06/30/2011 | US20110159078 Volatile Anesthetic Compositions and Methods of Use |
| 06/30/2011 | US20110159077 Pentoxifilin-based dermatological pharmaceutical composition, for topical application, in cream, gel, solution, emulsion, liposome and microcapsule form |
| 06/30/2011 | US20110159074 Wipe Article Comprising Lotion Composition Comprising Omega-6 Fatty Acid And Method Of Improving Skin Barrier Function |
| 06/30/2011 | US20110159070 Biomaterials and implants for enhanced cartilage formation, and methods for making and using them |
| 06/30/2011 | US20110159069 Medical Implants and Methods of Making Medical Implants |
| 06/30/2011 | US20110159066 Methods For Treating Parkinson's Disease |
| 06/30/2011 | US20110159062 Antiseptic compositions and uses thereof |
| 06/30/2011 | US20110159058 Film preparation containing loperamide hydrochloride |
| 06/30/2011 | US20110159054 Nanoparticulate bicalutamide formulations |
| 06/30/2011 | US20110159052 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 06/30/2011 | US20110159050 Amphiphilic proteins as morphology modifiers |
| 06/30/2011 | US20110159049 Pharmaceutical composition |
| 06/30/2011 | US20110159048 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications |
| 06/30/2011 | US20110159046 Controlled release formulations exhibiting an ascending rate of release |
| 06/30/2011 | US20110159045 Method of treating dysglycemia and glucose excursions |
| 06/30/2011 | US20110159044 Silver ion delivery platform |
| 06/30/2011 | US20110159039 Eliciting hcv-specific antibodies |
| 06/30/2011 | US20110159020 Transcription Factor for Killer Cell Activation, Differentiation and Uses Thereof |
| 06/30/2011 | US20110159019 2,4-diaminopyrimidine compound |
| 06/30/2011 | US20110159017 Trytophan catabolism in cancer treatment and diagnosis |
| 06/30/2011 | US20110159010 Compositions and Methods for Decreasing Type III Deiodinase Activity to Modulate Adiposity and Blood Glucose Levels |
| 06/30/2011 | US20110159009 Anti-vegf antibodies |
| 06/30/2011 | US20110159005 11-beta-hydroxysteroid dehydrogenase type 1 (11beta-hsd1) inhibitors and uses thereof |